CVS Health Q2 2022 Earnings Report
Key Takeaways
CVS Health's total revenues increased to $80.6 billion, up 11.0% compared to prior year. GAAP diluted EPS was $2.23 and Adjusted EPS was $2.40. The company raised its full-year 2022 GAAP diluted EPS guidance range to $7.23 to $7.43 from $6.93 to $7.13 and raised its full-year 2022 Adjusted EPS guidance range to $8.40 to $8.60 from $8.20 to $8.40. The company also raised its full-year 2022 cash flow from operations guidance range to $12.5 billion to $13.5 billion from $12.0 billion to $13.0 billion.
Total revenues increased to $80.6 billion, up 11.0% compared to prior year
GAAP diluted EPS of $2.23 and Adjusted EPS of $2.40
Paid down $1.5 billion of long-term debt
Enrolled six million active users on the Company’s individualized Health Dashboard since its launch earlier this year.
CVS Health
CVS Health
CVS Health Revenue by Segment
Forward Guidance
The Company raised its full-year 2022 GAAP diluted EPS guidance range to $7.23 to $7.43 from $6.93 to $7.13 and raised its full-year 2022 Adjusted EPS guidance range to $8.40 to $8.60 from $8.20 to $8.40. The Company also raised its full-year 2022 cash flow from operations guidance range to $12.5 billion to $13.5 billion from $12.0 billion to $13.0 billion.
Revenue & Expenses
Visualization of income flow from segment revenue to net income